Medtronic Neuromodulation is recalling approximately 11,789 Vanta Implantable Neurostimulators (Model 977006) because the batteries are draining faster than expected by healthcare providers and patients. This defect leads to the need for unexpected outpatient reprogramming or surgical replacement of the device earlier than anticipated. These devices were manufactured in the United States and distributed worldwide.
The premature loss of battery life causes the neurostimulator to stop providing therapy unexpectedly, requiring the patient to undergo additional surgical procedures for device replacement or frequent clinic visits for reprogramming.
Outpatient reprogramming or surgical replacement.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.